In the UK, most prostate cancers are diagnosed in men aged 75–79, but rates rise steeply from 45–49. Black men are also more ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Peter Ellis, 69, from Manchester tells us about his experience finding out he had prostate cancer after an unlucky golf ...

The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

For example, their much smaller peer, Mainz Biomed (NASDAQ: MYNZ) just announced a new collaboration agreement ... mRNA-based ...

The star shares the first symptom that led to his Stage 3 cancer diagnosis, how he's coping and why he wants others to be ...

Australia is on the brink of a healthcare revolution driven by DNA science that will save lives and prevent disease – but top ...

Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following ...

Researchers have created a groundbreaking antibody that combines targeting, delivery, and immune activation to treat cancer, ...